trial · primary record
Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
ALS (Amyotrophic Lateral Sclerosis)
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 11 |
| Primary completion | 2021-09-15 |
| Primary endpoint | Change in Treg Suppressive Function in the Blood From Baseline to Week 24. |
| Registry ID | NCT04055623 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:19.067Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04055623
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.